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ABSTRACT 
Introduction: Radiation planning approaches for liver radiation often do not consider the 
regional variation that can exist in liver function. This study dosimetrically compares 
functional liver image-guided hepatic therapy (FLIGHT) to standard stereotactic body 
radiation therapy (SBRT) plans. In the FLIGHT plans, functional data from hepatobiliary 
iminodiacetic acid (HIDA) single photon emission computed tomography (SPECT) scans 
serve as a road map to guide beam arrangement. While meeting the same target volume 
coverage, plans are optimized to reduce dose to high-functioning liver. Materials and 
Methods: The study included 10 patients with hepatocellular carcinoma (HCC) with 
baseline HIDA SPECT imaging. Standard SBRT plans which did not systematically 
incorporate these scans had previously been completed on all 10 plans. Retrospectively, 
FLIGHT plans were created based on the use of contours of relative liver function from 
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the HIDA SPECT as avoidance structures. Resulting dose to each relative functional liver 
structure was examined and compared qualitatively and using Wilcoxin rank-sum tests. 
Target coverage, doses to organs at risk (OARs), conformity index (CI), and gradient 
index (GI) were also evaluated. Results: While maintaining the same target coverage, 
FLIGHT plans reduced the mean dose to the high functioning liver by a median of 3.0 Gy 
(range 0.7 to 4.6 Gy), which represented a 31.4% mean reduction compared to standard 
planning. FLIGHT plans reduced the volume of high functioning liver receiving 15 Gy by 
a mean of 59.3 cc (range 7 to 170 cc), for a mean reduction of 41.9%. The mean dose to 
areas of liver function defined by 25% to 100% and 50% to 100% maximum was reduced 
with FLIGHT from 10.5 Gy to 8.5 Gy and from 10.5 Gy to 7.5 Gy, respectively ( p < 0.005 
for both comparisons). The FLIGHT plans’ mean CI and GI did not differ significantly from 
the standard plans’ ( p = 0.721 and 0.169, respectively). Conclusion: FLIGHT SBRT 
allows for field design and plan optimization individualized to a patient's baseline regional 
liver function to maximize hepatic functional reserve. This personalized approach is 
achieved without compromising target coverage or OAR sparing. 
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INTRODUCTION 
Liver malignancies, especially hepatocellular carcinoma, often arise in patients 
with cirrhosis, who can exhibit significant variability in their liver function. The primary 
methods of assessing the severity of cirrhosis are clinical scoring systems such as the 
Child-Turcotte-Pugh (CTP), modified end-stage liver disease, and albumin-bilirubin 
scores. The gold standard lab test for global liver function evaluation is indocyanine green 
retention at 15 minutes (ICG15). A main limitation of all these tests is the lack of 
information that they provide regarding regional variations in hepatic function within the 
liver of an individual patient, which are increasingly well described. The use of functional 
imaging in radiation planning approaches is not a new concept and has been applied in 
a number of disease sites, the earliest attempts being in lung radiation.123 Visualizing 
regional differences in hepatic function has become possible with functional imaging 
techniques such as technetium-99-mebrofenin (Tc99m) hepatobiliary iminodiacetic acid 
(HIDA) and Tc99m galactosyl human serum albumin scans, dynamic contrast enhanced 
(DCE) computed tomography (CT), and dynamic contrast enhanced magnetic resonance 
imaging, all of which have been validated to ICG15.45678 Expertise with different 
techniques can vary between institutions. At our institution, functional liver imaging has 
been done with HIDA scans, which provide a global liver function value as well as SPECT 
data, allowing a regional map of liver function to be generated. 
Functional liver image-guided hepatic therapy (FLIGHT) incorporates this 
functional data to minimize dose to functional liver. With standard RT planning, liver 
function is assumed to be homogeneous and plans are optimized to meet certain dose-
volume histogram constraints to avoid liver injury.9 Incorporating functional data in the 
 
 
planning process would be beneficial, especially in patients with poor baseline liver 
function where sparing of high functioning liver may reduce the risk of toxicity. This 
retrospective study was designed to investigate whether FLIGHT could result in better 
sparing of high functioning liver while maintaining comparable target coverage, organs at 
risk (OARs) sparing, and plan conformity compared to the standard SBRT plans. 
MATERIALS AND METHODS 
The study included patients with baseline HIDA scans who were treated with liver 
SBRT for hepatocellular carcinoma at a single institution between 2014 and 2017. For 
patient immobilization, either Pro-lok (CIVCO Radiotherapy, Coralville, IA) or Elekta 
(Elekta Oncology, Norcross, GA) stereotactic body frames were used. Abdominal 
compression was used as needed to keep diaphragm excursion below 1 cm. 
RELATIVE FUNCTIONAL LIVER CONTOURING 
Each patient's treatment planning CT was rigidly fused with the baseline HIDA 
SPECT scan using MIM software (MIM Software Inc, Cleveland, OH). Liver function was 
divided into the following quartiles based on percent of maximum uptake within the liver 
structure: low (0% to 25% max), low-intermediate (25% to 50% max), high-intermediate 
(50% to 75% max), and high (75% to 100%), and separate contours were created within 
the liver to encompass each functional level ( Figure 1 ). Contours corresponding to the 
higher levels of function were then used as avoidance structures for the FLIGHT plans. 
 
 
 
 
 
Fig. 1 SPECT HIDA scan fused to treatment planning CT (left) with contours of relative 
liver function based on HIDA SPECT scan (right). Liver function is represented by the 
following contours: low-intermediate (blue, 25% to 50%), high-intermediate (green, 50% 
to 75%), and high (magenta, 75% to 100%). (Color version of figure is available online.) 
TARGET STRUCTURE CONTOURING 
The gross tumor volume (GTV) was contoured based on triple-phase CT, magnetic 
resonance imaging, or PET scans. To account for tumor motion due to patient breathing, 
the internal target volume (ITV) was delineated using four-dimensional (4D) CT. The 
planning target volume (PTV) was a 0.5 cm radial and 0.8 to 1 cm cranio-caudal 
expansion from the ITV to account for day-to-day set-up error. Identical target volumes 
were used for the FLIGHT and standard SBRT plans. 
TREATMENT PLANNING 
The HIDA SPECT guided plans were optimized so that the target coverage would 
be equivalent between the FLIGHT plan and standard SBRT plan. The plan objectives 
were to have > 98% of the GTV being covered by 110% of the prescribed dose, and to 
have > 95% of the PTV covered by 100% of the prescribed dose. All plans were inverse 
 
 
planned using Eclipse version 11.0.31 (Varian Medical Systems; Palo Alto, CA) with the 
anisotropic analytical algorithm (AAA). The beam energy (6MV or 18MV) remained the 
same for all plans, but different geometric beam arrangements were used for the FLIGHT 
plans in order to maximize sparing of high functioning liver regions. Similar to typical liver 
SBRT planning, eight to ten non-coplanar, non-opposed fields were utilized for the HIDA 
SPECT guided plans. Figure 2 illustrates a sample FLIGHT plan, which has no beams 
entering from the left anterior oblique (LAO) angle in order to minimize entry dose to the 
high functioning portion of the liver, shown in the magenta contour. 
 
Fig. 2 Patient B: Beam arrangement of (A) standard SBRT plan, and (B) FLIGHT plan. 
High functioning liver (75% to 100% max) is shown in magenta. (Color version of figure 
is available online.) 
PLAN EVALUATION 
The resulting dose to each relative functional liver structure was compared between the 
FLIGHT and standard SBRT plans. To assess the effectiveness of high functioning liver 
sparing, mean dose and the volume receiving ≤ 15 Gy (V15) to each relative functional 
liver structure were collected and compared between plans. GTV and PTV were not 
excluded from the recorded V15. Additionally, the conformity and integrity of the HIDA 
SPECT guided SBRT plans were assessed by target volume coverage, doses to OARs, 
 
 
conformity index (CI), and gradient index (GI). The CI and GI were calculated using the 
formulae given below: 10 
𝐶𝐶𝐶𝐶 = 𝑃𝑃𝐶𝐶(𝑡𝑡ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑡𝑡𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒)
𝑃𝑃𝑃𝑃𝑃𝑃(𝑡𝑡ℎ𝑒𝑒𝑡𝑡𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑡𝑡𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒)  
𝐺𝐺𝐶𝐶 = 𝑃𝑃𝐶𝐶50%(50%𝑒𝑒𝑜𝑜𝑡𝑡ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑡𝑡𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒) 
𝑃𝑃𝑃𝑃𝑃𝑃(𝑡𝑡ℎ𝑒𝑒𝑡𝑡𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑡𝑡𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒)  
STATISTICAL ANALYSES 
All statistical analyses were performed using IBM SPSS Statistics v24. The following 
parameters were compared between FLIGHT and standard SBRT using Wilcoxin rank-
sum tests: mean dose to relative functional liver structures, conformality index and 
gradient index. 
RESULTS 
Ten patients who had baseline HIDA scans prior to SBRT were included in this analysis. 
Patient characteristics were as follows: 3 women and 7 men, aged 56 to 77 years, 7 with 
CTP Class A cirrhosis and 3 with CTP Class B. The prescriptions were as follows: 48 Gy 
in 3 fractions ( n = 5), 50 Gy in 5 fractions ( n = 2), and 40 Gy in 5 fractions ( n = 3). 
DOSE TO THE RELATIVE FUNCTIONAL LIVER STRUCTURES 
Beam arrangements were changed in the FLIGHT plans to avoid the highest functioning 
liver in all 10 cases. Figure 3 demonstrates the difference in dose distribution that can be 
achieved with FLIGHT planning. The 15 Gy isodose line in the FLIGHT plan ( Fig. 3 B) 
clearly avoids the area of high functioning liver which had received low doses of radiation 
in the standard plan ( Fig. 3 A). 
 
 
 
Fig. 3 Patient C: 15Gy isodose displayed for (A) standard SBRT plan, and (B) FLIGHT 
plan. 
The mean dose to the functioning liver (25% to 100%) was reduced by a mean of 20.1%, 
and the same parameter for the high functioning liver (50% to 100%) was reduced by a 
mean of 31.4%. The median absolute reduction in dose to functioning liver (25% to 100%) 
was 2.0 Gy (range 0.6 to 2.9 Gy) and the median reduction in dose to high functioning 
liver (50% to 100%) was 3.0 Gy (range 0.7 to 4.6 Gy). After adjusting all prescriptions 50 
Gy so that absolute mean doses could be compared, the mean dose to functioning liver 
was reduced with FLIGHT planning ( p < 0.005 for both comparisons, Table 1 ). 
Table 1 
 
Standard FLIGHT p Value 
Mean dose to 25% to 100% max functioning liver (+/− stdev) 10.5 Gy 
(+/− 4.4 Gy) 
8.5 Gy 
(+/− 3.8 Gy) 
0.005 
Mean dose 50% to 100% max functioning liver (+/− stdev) 10.5 Gy 
(+/− 5.4 Gy) 
7.5 Gy 
(+/− 4.5 Gy) 
0.005 
 
 
 
The percent of the volume of 25% to 100% functioning liver receiving 15 Gy was reduced 
by a mean of 21.9%, and the same parameter for the 50% to 100% functioning liver was 
reduced by a mean of 41.9%. The mean absolute volume reduction of structures receiving 
> 15 Gy was 77.4 cc for 25% to 100% functioning liver (range −6 to 176 cc) and 59.3 cc 
(range 7 to 170 cc) for 50% to 100% functioning liver. 
PLAN CONFORMITY AND SPARING OF OARS 
FLIGHT plans’ CI and GI were not significantly different from standard SBRT plans ( Table 
2 ). There were 2 plans treated with 48 Gy in 3 fractions in which the volume receiving > 
30 Gy was > 30 cc with the standard plans. In these cases, the volume of chestwall 
receiving > 30 Gy with the FLIGHT plan was kept below that of the standard plan. In one 
of these cases, the coverage of the GTV and PTV had to be compromised due to 
proximity to the chestwall. The coverage of the GTV and PTV was kept at or above that 
delivered with the standard plans. 
Table 2 
 
Standard FLIGHT p Value 
Conformality index 1.04 1.02 0.721 
Gradient index 3.73 3.50 0.169 
 
 
 
 
 
DISCUSSION 
FLIGHT planning is a technique for individualizing radiation plans based on a patient's 
organ function. By placing integral dose in non- or low-functioning areas of the liver, thus 
avoiding high-functioning liver, hepatic functional reserve will theoretically be maximized. 
This study demonstrated that FLIGHT planning with HIDA scans is feasible and spares 
higher-functioning liver that otherwise would have received dose had the level of function 
not been known. The University of Michigan previously demonstrated that liver function 
can change during and post-treatment, and suggested that adapting a plan to direct dose 
through worse functioning liver may be feasible. 6 
The benefit of FLIGHT planning is highly patient dependent, and certain patients may 
benefit more from this approach than others. This has been noted by the University of 
Washington as well in their differential hepatic avoidance radiation therapy approach 
using sulfur colloid scans. 11 Some plans, as shown in Figure 3, did not use beams from 
all potential angles. Notably, there was no change in conformity or gradient indices as a 
consequence of this. There was significant variation between patients in the location and 
the volume of the high functioning liver. Six patients had a reduction in mean dose to the 
high functioning liver (50% to 100%) of ≥ 3 Gy. Some patients’ high functioning liver was 
large and distal from the target volume, which made it easier to avoid. On the other hand, 
others were challenging to avoid due to the proximity to the target ( Fig. 4 ). The quality 
of the registration of the HIDA to the planning CT is important, especially in cases where 
areas of high function are close to the target. There can be limitations with a rigid fusion 
of the SPECT HIDA with the planning CT, especially in cases where significant abdominal 
 
 
compression is used in a tumor of the left lobe of the liver, for example. In practice, clinical 
judgment as to the priority of functional avoidance is needed. 
 
Fig. 4 Variation in the location and volume of the high functioning liver for Patient D (left) 
and Patient E (right). GTV and PTV are shown in red and cyan contours, respectively. 
(Color version of figure is available online.) 
The study was limited by sample size and its retrospective nature. The magnitude of the 
clinical benefit cannot be assessed by this dosimetric evaluation, but these preliminary 
results are encouraging. An analysis of post-treatment decompensation with the FLIGHT 
approach has been published, suggesting that functional dosimetric endpoints can 
complement current assessments of liver function. 12 This proof of concept approach 
formed the basis for the prospective FLIGHT study at our institution. 
CONCLUSION 
FLIGHT plans successfully spared functional liver while maintaining similar target 
coverage and conformity to conventional SBRT plans. The ability to spare functional liver 
without any measurable compromises demonstrates that FLIGHT planning is a 
 
 
reasonable approach, especially in patients with poor baseline liver function who may 
benefit from any incremental improvement in the plan. Evaluating FLIGHT prospectively 
may further elucidate its clinical benefit. 
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